CK26-0193: Improving awareness and knowledge of alpha-gal syndrome (AGS) in the United States.

Sponsor: CDC
Internal Deadline: 05/29/2026
Institutional Submission Limit: 1
Program Website

This NOFO’s aim is to improve awareness and knowledge of alpha-gal

syndrome (AGS) in the United States. AGS is an emerging condition and is not

nationally notifiable. This will happen through:

• The creation of a professional network of AGS researchers and public

health professionals.

• Improved surveillance.

• Improved communications materials.

This NOFO seeks to improve:

• AGS surveillance.

• Patient care.

• Awareness and understanding.

The NOFO’s three main strategies are to:

• Share: Disseminate the latest knowledge about AGS among stakeholders

to improve patient care for AGS and the public health response.

? This includes public health agencies, academic researchers, and

advocacy groups.

• Track: Conduct active or enhanced surveillance for AGS.

? This strategy could involve patient populations or geographic

locations with limited access to specialized healthcare provider care.

• Educate: Create AGS communications targeted at the general public, AGS

patients, and/or people at higher risk for tick encounters (outdoor

enthusiasts, dog owners, etc.).

 

Under this NOFO, you may submit only one application under your

organization’s UEI.

 

 

Submission Process

Limited submissions MUST be coordinated with the Office of the Vice President for Research.

If interested in applying for this opportunity, please combine the following items into a single PDF and email to resdev@mailbox.sc.edu by 5pm on the INTERNAL DEADLINE above:

• Cover page with grant program name & number (if applicable) to which you are applying, your project title, PI (name, department/unit, & email), and list of co-PIs/key collaborators (name & department/unit)
• a two-page project abstract addressing key components/criteria for this specific grant program
• a 2-3 page CV/biosketch for the PI (SCiENcv preferred)